• 제목/요약/키워드: Pharmacodynamic study

검색결과 50건 처리시간 0.027초

Florfenicol-amoxicillin 혹은 florfenicol-cefuroxime 병용투여시 어류 병원성 세균에 대한 약역학 (Pharmacodynamics of florfenicol alone and in combination with amoxicillin or cefuroxime against pathogenic bacteria of fish origin)

  • 이은미;최명진;이승진;박승춘
    • 대한수의학회지
    • /
    • 제50권4호
    • /
    • pp.279-284
    • /
    • 2010
  • Combination therapy of antibiotics is leading to improved efficacy or safety profiles with decrease emergence of bacterial resistance. Because of this benefit, many of antibacterial combinations have been used in veterinary practice for the past few decades. The purpose of this study was to examine the in vitro activity of an amoxicillin alone and in combination with other antibiotics against pathogenic bacteria of fish origin. Based on the fractional inhibitory concentration (FIC) index (FIC $$\leq_-$$ 0.5), a synergistic interaction was shown in combination of florfenicol with amoxicillin or cefuroxime. The combination of florfenicol and amoxillin showed higher antibacterial activity than that of florfenicol and cefuroxime. Ratio of amoxicillin and florfenicol in combination was 1 : 1, which showed the antibacterial activity against bacterial isolates of fish as compared with other ratios. A synergetic effect of the combination (amoxicillin and florfenicol) was further confirmed in the time-kill curve study. The study showed a better in vitro antibacterial activity of a 1 : 1 combination of amoxicillin and florfenicol than the individual antibacterial against bacterial isolates of fish. In conclusion, the combination of florfenicol and amoxicillin may serve as a potential antibacterial therapy in fishes infected pathogenic bacteria.

누에분말 추출물의 이당류 경구투여에 대한 동력학적 연구 (Pharmacodynamic Study of Silkworm Powder in Mice Administered to Maltose, Sucrose and Lactose)

  • 류강선;이희삼;김선여
    • 한국잠사곤충학회지
    • /
    • 제41권1호
    • /
    • pp.9-13
    • /
    • 1999
  • 누에분말 투여에 따른 시간별 당의 흡수패턴 및 당분해 억제로 당의 손실여부를 알아보기 위하여 12시간동안 절식된 마우스에 이당류(Maltose, Sucrose, Lactose)와 누에분말 메탄올 추출물을 동시에 투여하여 240분동안에 혈당 변화를 측정하였다. 1. Maltose와 누에분말을 투여한 군에서는 투여 30분 후에 69.0%의 혈당상승억제효과를 보였으며, 60분이후에도 당이 서서히 흡수되고 있어 지연흡수가 잘 유도되고 있었다. Maltose 군의 투여 240분까지의 당흡수는 560.7 mg/dl이고, 누에분말군은 534.7 mg/dl로써 Maltose 투여대비 95.4%로 누에분말이 당의 손실없이 당의 흡수를 지연시켰다. 2. Sucrose와 누에분말 투여군은 투여 30분 후 혈당상승억제효과가 59.9%로 maltose과 거의 같은 수준이며, 60분 이후의 당흡수 패턴 또한 maltose과 유사하였다. Sucrose 군의 투여 240분까지의 당흡수는 508.9 mg/dl이고, 누에분말군은 468.8 mg/dl로 Sucrose 투여대비 92.1%로서 누에분말 투여가 당을 지연 흡수시켰다. 3. Lactose와 누에분말 투여군은 투여 30분 후 약간의 혈당상승을 억제하였으나, lactose 투여군과 비슷한 당흡수 패턴을 유지하여 누에분말은 lactose의 흡수를 억제하지 못하였다. 이상의 결과로 누에분말은 ${\alpha}$-glucose를 억제하여 투여 30분 후의 일시적인 혈당상승을 유발하지 않고 또한 당의 손실이 거의 없이 당의 지연흡수를 유도하고 있음이 입증되었다.

  • PDF

I-131 표지 Curcumin의 약동력학적 분석을 통한 귀경(歸經)연구 (Study on the Attributive Channel Theory by the Pharmacodynamic Research of I-131 labelled Curcumin)

  • 윤홍일;함인혜;조정혁;유국현;박정훈;최호영
    • 대한본초학회지
    • /
    • 제22권2호
    • /
    • pp.181-188
    • /
    • 2007
  • Objectives : This study was to verify the Attributive Channel theory of herbal medicine. Methods : [13lI]iodocurcumin was synthesized, separated, and refined from curcumin, the major component of Curcuma species, followed by observing the biodistribution in an organism. Especially, from the fact that curcumin has shown to possess potent anti-carcinogenic properties, the biodistribution in the carcinogenesis organism was analyzed. Result : Iodocurcumin 23mg was obtained through column chromatography after a reaction with 50mg of Curcumin and ICl. The nominal yield of [13lI]iodocurcumin synthesis was 35% when checked with radioactive layer of chromatography. [13lI]iodocurcumin was most largely distributed in the stomach of a BALB/c mouse and a C57BL/6 mouse transplanted with Lewis lung carcinoma cell. Conclusion : The fact that [13lI]iodocurcumin was most largely distributed in the stomach was related with the Attributive Channel theory. And there was no significant finding related to tumor cells.

  • PDF

흰쥐 대뇌피질의 뇌파에 대한 diazepam 및 flumazenil의 약력학적 상호작용 (Pharmacodynamic Interactions of Diazepam and Flumazenil on Cortical Eeg in Rats)

  • 이만기
    • Biomolecules & Therapeutics
    • /
    • 제7권3호
    • /
    • pp.242-248
    • /
    • 1999
  • Diazepam, a benzodiazepine (BDZ) agonist, produces sedation and flumazenil, a BDZ antagonist, blocks these actions. The aim of this study was to examine the effects of BDZs on cortical electroencephalogram (EEG) in rats. The recording electrodes were implanted over the frontal and parietal cortices bilaterally, and the reference and ground electrodes over cerebellum under ketamine anesthesia. To assess the effects of diazepam and flumazenil, rats were injected with diazepam (1 mgHg, i.p.) and/or flumazenil ( 1 mg/kg, i.p.), and the EEG was recorded before and after drugs. Normal awake had theta peak in the spectrum and low amplitude waves, while normal sleep showed large amplitude of slow waves. The powers of delta, theta and alpha bands were increased during sleep compared with during awake. Diazepam reduced the mobility of the rat and induced sleep with intermittent fast spindles and large amplitude of slow activity, and it produced broad peak over betaL band and increased the power of gamma band, which were different from EEG patterns in normal sleep. Saline injection awakened rats and abolished fast spindles for a short period about 2-5 min from EEG pattern during diazepam-induced sleep. Flumazenil blocked both diazepam-induced sleep and decreased the slow activities of delta, theta, alpha and betaL, but not of gamma activity for about 10 min or more. This study may indicate that decrease in power of betaL and betaH bands can be used as the measure of central action of benzodiazepines, and that the EEG parameters of benzodiazepines have to be measured without control over the behavioral state by experimenter.

  • PDF

Pharmacodynamic evaluation of hypoglycemic effect of Damtab in healthy adult male volunteers

  • Sahu, Pratap Kumar;Pillai, KK;Saha, Nilanjan;Sharma, Manju;Najmi, AK
    • Advances in Traditional Medicine
    • /
    • 제7권2호
    • /
    • pp.205-210
    • /
    • 2007
  • The objectives of the study were (1) To evaluate the safety and tolerability of Damtab. (2) To characterize hypoglycemic effect of Damtab, if any. (3) To evaluate insulin sensitivity effect of Damtab, if any. Hypoglycemic effect of Damtab (700 mg and 1,400 mg) were examined. Gliclazide (80 mg) was used as an active control. Placebo was used as control. Breakfast was given, half an hour before dosing whereas lunch, snacks and dinner were given at 6, 10 and 14 h post dose. An oral glucose tolerance test was conducted to calculate the insulin sensitivity index from the values of glucose and insulin during oral glucose tolerance test. Both giclazide 80 mg and Damtab 1,400 mg significantly lowered plasma glucose level up to 6 h. Insulin sensitivity index of Damtab (1,400 mg) was found to be similar to that of placebo. A significant increase in insulin level at 1 h post dose of Damtab (1,400 mg) was observed. Damtab 700 mg shows placebo like effect whereas Damtab 1,400 mg possesses hypoglycemic effect.

한방안이비인후피부과학회지에 게재된 알레르기성 접촉 피부염의 실험논문에 대한 고찰 (The Review on the Experimental Studies of Allergic Contact Dermatitis Published in The Journal of Korean Medical Ophthalmology & Otolaryngology & Dermatology)

  • 조영선;김경준
    • 한방안이비인후피부과학회지
    • /
    • 제29권4호
    • /
    • pp.78-94
    • /
    • 2016
  • Objectives : This study was carried out to analyze the trends of clinical studies of allergic contact dermatitis published in the Journal of Korean Medical Ophthalmology & Otolaryngology & Dermatology. Methods : We studied 10 research papers on allergic contact dermatitis published in JKOOD. We analyzed about experiment methods, pharmacodynamic effects, therapeutic effects in published papers. Results : 1. The number of searched journal is 10 papers. 2. All experiments was performed using DNCB primed mouse. To demonstrate therapeutic effect of drugs, previous researches observed dermatological and histopathogical conditions, erythema, melasma, white blood cell count, Lymphocyte ratio to white blood cell. 3. Most of drugs have heat-clearing and detoxifying effects. 4. Every drugs have positive effect in treating allergic contact dermatitis. Conclusions : Figuring out how experiment proceeded and tendency of drugs in researching allergic contact dermatitis is significance of this paper. Further research about drugs and their treating methods should be carried out to improve curative effectiveness for allergic contact dermatitis.

새로운 당뇨병 치료제 Pramlintide의 Systematic Review (Systemic Review of Pramlintide, a New Drug for the Treatment of Diabetes Mellitus)

  • 스리니바산 샨무감;정희용;용철순;최한곤;김정애;유봉규
    • 약학회지
    • /
    • 제50권6호
    • /
    • pp.386-392
    • /
    • 2006
  • Pramlintide, a synthetic analogue of human hormone amylin, is the first of a new class of amylinomimetic compounds. Present study was undertaken to compile and analyze the clinical trials of pramlintide, and thereby to facilitate the design of the bridging study for the earlier introduction of the drug, which might be needed by diabetes patients in Korea. Sixty-two articles from Pubmed and MEDLINE search were used to analyze the trials of pramlintide along with prescribing information and New Drug Application packet obtained form the manufacturer. The efficacy of the new drug was attributed to three mechanisms: delay of gastric emptying time, inhibition of post-prandial glucagon secretion, and reduction of food intake by enhanced satiety. Clinical trials consistently identified the effectiveness of the drug for the treatment of type 1and type 2 diabetes who have failed to achieve glycemic control despite optimal therapy with insulin. However, the six pivotal Phase III clinical trials were peformed with mostly caucasian and some black and hispanic people. None of the trials documented the proportion of either Asian or Korean participants. Since Korean diabetes patients show different epidemiology and characteristics in their disease state, it appears that the bridging study of pramlintide should be designed in the level of full scale Phase III clinical trial along with pharmacokinetic and pbarmacodynamic studies.

The Effects of Donepezil, an Acetylcholinesterase Inhibitor, on Impaired Learning and Memory in Rodents

  • Shin, Chang Yell;Kim, Hae-Sun;Cha, Kwang-Ho;Won, Dong Han;Lee, Ji-Yun;Jang, Sun Woo;Sohn, Uy Dong
    • Biomolecules & Therapeutics
    • /
    • 제26권3호
    • /
    • pp.274-281
    • /
    • 2018
  • A previous study in humans demonstrated the sustained inhibitory effects of donepezil on acetylcholinesterase (AChE) activity; however, the effective concentration of donepezil in humans and animals is unclear. This study aimed to characterize the effective concentration of donepezil on AChE inhibition and impaired learning and memory in rodents. A pharmacokinetic study of donepezil showed a mean peak plasma concentration of donepezil after oral treatment (3 and 10 mg/kg) of approximately $1.2{\pm}0.4h$ and $1.4{\pm}0.5h$, respectively; absolute bioavailability was calculated as 3.6%. Further, AChE activity was inhibited by increasing plasma concentrations of donepezil, and a maximum inhibition of $31.5{\pm}5.7%$ was observed after donepezil treatment in hairless rats. Plasma AChE activity was negatively correlated with plasma donepezil concentration. The pharmacological effects of donepezil are dependent upon its concentration and AChE activity; therefore, we assessed the effects of donepezil on learning and memory using a Y-maze in mice. Donepezil treatment (3 mg/kg) significantly prevented the progression of scopolamine-induced memory impairment in mice. As the concentration of donepezil in the brain increased, the recovery of spontaneous alternations also improved; maximal improvement was observed at $46.5{\pm}3.5ng/g$ in the brain. In conclusion, our findings suggest that the AChE inhibitory activity and pharmacological effects of donepezil can be predicted by the concentration of donepezil. Further, $46.5{\pm}3.5ng/g$ donepezil is an efficacious target concentration in the brain for treating learning and memory impairment in rodents.

국내 3차 병원의 비만 암환자에서 각각 다른 체중 측정 공식들을 적용한 piperacillin/tazobactam의 용량 적절성 비교 연구 (Comparison of Appropriate Piperacillin/Tazobactam Doses in Korean Obese Patients with Cancer Based on Different Body Size Descriptor Equations in a Tertiary Care Hospital)

  • 김지현;양영모;윤현옥;최은주
    • 한국임상약학회지
    • /
    • 제27권2호
    • /
    • pp.83-91
    • /
    • 2017
  • Background: Piperacillin/tazobactam (TZP) is an antibiotic against a broad spectrum of gram-positive, gram-negative, and aerobic and anaerobic strains of bacteria. Due to changes in its pharmacokinetic and pharmacodynamic parameters by TZP-treated patients' renal functions and obesity, it is important to administrate and monitor TZP based on their renal functions and Body Mass Index (BMI) levels. The purpose of this study was to determine the appropriateness of administration doses of TZP based on renal functions of obese cancer patients in a tertiary hospital. Methods: This study was retrospectively conducted with obese cancer patients with $BMI{\geq}30kg/m^2$ in a tertiary hospital, Korea from September 2004 to August 2014. Data were collected through Electronic Medical Record (EMR) which contained laboratory data and TZP dosing of each patient. Results: Among 7,058 patients during the study period, 102 prescriptions were selected based on inclusion and exclusion criteria and classified by their renal functions. Although TZP should be used based on patients' renal functions to adjust its dose, its initial dose and dosing interval were consistently used without considering patients' renal functions on a regular basis. Especially, in the comparison with FDA dosing standard of TZP, approximately twice patients with $20mL/min{\leq}CrCl{\leq}40mL/min$ received domestically 4.5 g instead of 2.25 g as the TZP starting dose. Conclusion: The appropriate doses of TZP were administered to almost all of obese cancer patients; however, the recommended TZP dose was different between Korea and other countries by twice the amount. Further related studies are necessary to clearly determine the results, to optimize TZP treatment for obese patients with cancer in clinical practice, and to design and develop new TZP formulations for them in pharmaceutical industry.

Clozapine 투여로 인한 타액 과잉분비에 대한 Clonidine의 치료효과 (Clonidine Treatment of Clozapine-Induced Hypersalivation)

  • 이형근;박인준;권영준;정희연
    • 생물정신의학
    • /
    • 제7권1호
    • /
    • pp.80-84
    • /
    • 2000
  • Clozapine의 부작용 중 타액의 과잉분비의 원인을 알아보기 위하여 순천향대학교 천안병원 신경정신과에 입원한 환자 중 정신분열병 환자 21명(남자 12명, 여자 9명)을 대상으로 시행한 본 연구결과는 다음과 같다. 1) 정신분열병 환자에게 clozapine을 투여한 후 타액의 분비는 유의하게 증가하였다. 2) Clozapine을 투여한 후 타액의 과잉분비를 보인 정신분열병 환자에게 clonidine을 투여한 후 타액의 분비는 유의하게 감소하였다. 3) Clozapine에 의한 타액의 과잉분비는 ${\alpha}$-아드레날린성 작용에 의한다는 것을 강하게 시사한다.

  • PDF